NMD Pharma A/S - Danish company profile

CVR: 36899069 Active

Company information

Company type
Aktieselskab
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Address
Palle Juul-Jensens Boulevard 82, 8200 Aarhus N
Employees
20 (ANTAL_20_49)
Share capital
5.497.789 DKK
Founded
2015-05-07
Status
NORMAL
Municipality
AARHUS

About NMD Pharma A/S

NMD Pharma A/S is a Danish company registered under CVR number 36899069 in Aarhus N. The company is listed as Aktieselskab and operates in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik, with registration history from 2015. DanishCompanyCheck combines public registry data, financial filings, ownership records and compliance signals in one English company profile.

Financial statements

YearRevenueResultEquityTotal assets
2024--32.253.700 kr.35.394.591 kr.39.393.694 kr.
2023--22.401.436 kr.42.672.873 kr.46.392.625 kr.
2022--12.323.989 kr.25.132.967 kr.27.138.564 kr.
2021--13.614.082 kr.2.595.580 kr.4.919.746 kr.
2020--9.928.027 kr.9.243.117 kr.11.488.549 kr.

Management and ownership

NameRoleOwnership
Christian Ellebæk EllingBESTYRELSESMEDLEM-
Thomas Holm PedersenDIREKTØR-
Thomas Holm PedersenBESTYRELSESMEDLEM-
João Carlos Ribas de AlmeidaBESTYRELSESMEDLEM-
CLAUS OLESEN HOLDING ApSSTIFTERE-
EY Godkendt RevisionspartnerselskabREVISION-
ALSOF Holding ApSSTIFTERE-
OBNmotus holding ApSSTIFTERE-
Jeremy Paul SpringhornBESTYRELSESMEDLEM-
Sabine Kohar DandiguianBESTYRELSESMEDLEM-
David William EvansBESTYRELSESMEDLEM-
Michael Thomas HeffernanFORMAND-
Ivan Andreevich BurkovBESTYRELSESMEDLEM-

Production units

P numberNameAddressIndustry
1020416218NMD Pharma A/SPalle Juul-Jensens Boulevard 82, 8200, Aarhus NForskning og eksperimentel udvikling inden for naturvidenskab og teknik
1029145233NMD Pharma Kbh.Fruebjergvej 3, 2100, København ØForskning og eksperimentel udvikling inden for naturvidenskab og teknik

Use this profile for due diligence

Use this page to verify company identity, registration status, financial history, management and ownership before trading with a Danish counterparty.